StockData
Solventum Corp logo

Solventum Corp (SOLV) stock

SOLVNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/3089% above fair value
$86.48+0.42 (+0.49%)

Close on Nov 18, 2026Market cap $14.72BP/E 97.2Yield –

Solventum free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Solventum's free cash flow for the twelve months ending Sep 30, 2026 was $0, down 100.0% year over year. For fiscal 2025 it was -$10.00M, down 101.2% from the year before.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$10.00M-101.2%
FY2024Dec 31, 2024$805.00M-50.5%
FY2023Dec 31, 2023$1.63B+13.8%
FY2022Dec 31, 2022$1.43B–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$97.00M–
Q2 FY2026Jun 30, 2026$144.00M+144.1%
Q1 FY2026Mar 31, 2026-$273.00M–
Q4 FY2025Dec 31, 2025$32.00M-65.2%
Q3 FY2025Sep 30, 2025-$21.00M-127.6%
Q2 FY2025Jun 30, 2025$59.00M-80.1%
Q1 FY2025Mar 31, 2025-$80.00M-123.5%
Q4 FY2024Dec 31, 2024$92.00M-80.0%
Q3 FY2024Sep 30, 2024$76.00M-82.2%
Q2 FY2024Jun 30, 2024$297.00M+0.7%
Q1 FY2024Mar 31, 2024$340.00M-23.4%
Q4 FY2023Dec 31, 2023$459.00M–
Q3 FY2023Sep 30, 2023$427.00M–
Q2 FY2023Jun 30, 2023$295.00M–
Q1 FY2023Mar 31, 2023$444.00M–

More Solventum figures

See a number that looks wrong?